Scientists test revolutionary immune cell therapy for debilitating muscle disease
Disease control
Recruiting now
This is an early-stage safety study testing a new type of treatment called anito-cel for adults with generalized myasthenia gravis, a chronic autoimmune disease that causes severe muscle weakness. The therapy involves collecting a patient's own immune cells, genetically modifying…
Phase: PHASE1 • Sponsor: Arcellx, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC